This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
The below stocks have been identified as having potential to register bigger than normal share price moves (up or down) today based on the news cited
Headlam (HEAD.L) – warned on first half and year profit, blaming poor trading in its first quarter. Both Britain and Europe had shown signs of contraction during the first six months of 2013. Forecast first half earnings about 10% lower than last year and said uncertainty around its trading performance during the H2 was likely to prevail. Closing Price 362.13p (Reuters)
Hikma Pharmaceuticals (HIK.L) – said it expects revenue to rise 17% in 2013, up from its previous forecast of 13%, boosted by strong sales of its generic antibiotic doxycycline. The company said it expected full-year revenue of about £200m and operating margins of more than 30% in its generic business. Closing Price 994.00p (Reuters)
Bovis Homes Group (BVS.L) – 40% increase in private reservations. Added 2,767 new consented plots to the land bank. Private sales rate per site per week improved by 26% to 0.59. Average sales price on legal completions +15% to £188,500. Expects to post housing operating margin approaching 11%. ROCE can be further improved in 2013 to circa 10. Closing Price 775.00p (Reuters)
Gulf Keystone Petroleum (GKP.L) – Remains surprised that M&G chose unilaterally to nominate the four candidates. Disingenuous for M&G to refer to proposed appointment of Jeremy Asher as an independent non-executive director. Jeremy Asher is not independent, due to his interests in a significant shareholding in Gulf Keystone. Expects to publish its recommendation to shareholders on M&G board candidates shortly. Closing Price 157.75p (Reuters)
For more information on any of these individual news items, call into the trading floor
| Stock | Code | Close | High | Low |
| UK 100 | UKX | -0.72% | 1.20% | -0.89% |
| Wall Street | DJI | 0.98% | 0.99% | -0.12% |
| German 30 | DAX | -2.36% | 0.47% | -2.36% |
| RECKITT-BENCKISER | RB.L | 0.38% | 2.12% | -0.44% |
| UNILEVER | ULVR.L | -0.40% | 1.46% | -0.91% |
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance. Prepared by Michael van Dulken, Head of Research